A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)

Sponsor
Hoffmann-La Roche (Industry)
Overall Status
Recruiting
CT.gov ID
NCT04374253
Collaborator
(none)
2,032
277
2
70.7
7.3
0.1

Study Details

Study Description

Brief Summary

This is an open-label, multicenter, rollover study to evaluate the safety, tolerability, and efficacy of long-term administration of open-label gantenerumab in participants with AD who completed Study WN29922 or WN39658, either the double-blind or open-label extension (OLE) part.

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

Participants who were in the active arm in the double blind part and those who have completed OLE part in the parent study, will continue receive open-label gantenerumab 510 mg sub-cutaneously (SC) every 2 weeks (Q2W). Participants who are naive to gantenerumab treatment will be required to undergo the 3 step uptitration scheme as in the parent study before receiving target dose of open label gantenerumab.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
2032 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
An Open-Label, Multicenter, Rollover Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease
Actual Study Start Date :
Feb 1, 2021
Anticipated Primary Completion Date :
Dec 25, 2026
Anticipated Study Completion Date :
Dec 25, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group 1

Participants, who completed the double-blind part and did not enter the OLE part of Study WN29922 or WN39658, will be enrolled and receive open-label gantenerumab approximately 2 weeks after the Week 116 visit of Study WN29922 or WN39658. This will be considered the OLE baseline visit (OLE Day 1).

Drug: Gantenerumab
Group 1 participants who were in the active arm in the double blind part in the parent study (WN29922 or WN39658), will continue to receive open-label gantenerumab 510 mg SC, Q2W. Participants who are naive to gantenerumab treatment will be required to undergo the 3 step uptitration scheme before receiving target dose of open label gantenerumab, 510 mg SC, Q2W.

Experimental: Group 2

Participants, who completed the double-blind part and the OLE part of Study WN29922 or WN39658, will be enrolled and receive open-label gantenerumab approximately 2 weeks after the OLE Week 34 visit or the final dose visit in the Study WN29922 or WN39658 OLE.

Drug: Gantenerumab
Group 2 participants who have completed OLE part in the parent study (WN29922 or WN39658), will continue to receive open-label gantenerumab 510 mg SC, Q2W

Outcome Measures

Primary Outcome Measures

  1. Percentage of Participants with Adverse Events (AEs) and Serious Adverse Events (SAEs) [From Baseline (OLE Day 1) to Week 208]

  2. Change in Columbia-Suicide Severity Rating Scale (C-SSRS) Score [From Baseline (OLE Day 1) to Week 208]

  3. Percentage of Participants with Amyloid-Related Imaging Abnormalities-Edema (ARIA-E) Confirmed by Magnetic Resonance Imaging (MRI) [From Baseline (OLE Day 1) to Week 208]

  4. Percentage of Participants with Amyloid-Related Imaging Abnormalities-Haemosiderin deposition (ARIA-H) Confirmed by MRI [From Baseline (OLE Day 1) to Week 208]

  5. Percentage of Participants with Injection-Site Reactions (ISRs) [From Baseline (OLE Day 1) to Week 208]

Secondary Outcome Measures

  1. Change in Clinical Dementia Rating (CDR) Score [From Baseline (OLE Day 1) to Week 208]

  2. Change in Mini-Mental State Examination (MMSE) Score [From Baseline (OLE Day 1) to Week 208]

  3. Change in Alzheimer Disease Assessment Scale-Cognition, Subscale 11 (ADAS-Cog11) Score [From Baseline (OLE Day 1) to Week 208]

  4. Change in Alzheimer Disease Assessment Scale-Cognition, Subscale 13 (ADAS-Cog13) Score [From Baseline (OLE Day 1) to Week 208]

  5. Change in Verbal Fluency Task Score [From Baseline (OLE Day 1) to Week 208]

  6. Change in Coding [From Baseline (OLE Day 1) to Week 208]

  7. Change in Functional Activities Questionnaire (FAQ) Score [From Baseline (OLE Day 1) to Week 208]

  8. Change in Alzheimer Disease Cooperative Study Group-Activities of Daily Living (ADCS-ADL) Score [From Baseline (OLE Day 1) to Week 208]

  9. Percentage of Participants with Anti-drug Antibody (ADA) to Gantenerumab [From Baseline (OLE Day 1) to Week 208]

Other Outcome Measures

  1. Plasma Concentration of Gantenerumab Administered SC [From Baseline (OLE Day 1) to Week 208]

    Re-classified as 'Other Pre-specified' due to sparse PK sampling, to support population PK analysis of the data which is an exploratory analysis.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Completed Study WN29922 or WN39658, either its double-blind part or OLE part, and did not discontinue study drug early

  • The participant should be capable of completing assessments either alone or with the help of the caregiver

  • Availability of a person (referred to as the "caregiver")

  • For women of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use contraception methods with a failure rate of <1% per year (bilateral tubal ligation, male sterilization, hormonal contraceptives that inhibit ovulation, hormone-releasing intrauterine devices, and copper intrauterine devices) during the treatment period and for at least 16 weeks after the final dose of gantenerumab

  • Agreement not to donate blood or blood products for transfusion for the duration of the study and for 1 year after final dose of study drug

Exclusion Criteria:
  • Pregnant or breastfeeding, or intending to become pregnant during the study or within at least 16 weeks after the final dose of study drug

  • Prematurely discontinued from Study WN29922 or WN39658

  • Any medical condition that may jeopardize the participant's safety if he or she continues to receive study treatment

  • Received any investigational treatment other than gantenerumab during or since completion of Study WN29922 or WN39658, either its double-blind or OLE part

  • Evidence of disseminated leptomeningeal hemosiderosis

  • Evidence of intracerebral macrohemorrhage

  • Use of prohibited medication

  • Evidence of ARIA-E on the last MRI scan report in Study WN29922 or WN39658, either its double-blind or OLE part

Contacts and Locations

Locations

Site City State Country Postal Code
1 Banner Alzheimer's Institute Phoenix Arizona United States 85006
2 Barrow Neurological Institute Phoenix Arizona United States 85013
3 Banner Sun Health Research Insitute Sun City Arizona United States 85351
4 Health Initiatives Research, PLLC Fayetteville Arkansas United States 72703
5 Fullerton Neurology and Headache Center Fullerton California United States 92835
6 Neurology Center of North Orange County Fullerton California United States 92835
7 Irvine Center for Clinical Research Irvine California United States 92614
8 Desert Valley Research Redlands California United States 92374
9 Sutter Medical Group, Neurology Sacramento California United States 95816
10 Syrentis Clinical Research Santa Ana California United States 92705
11 California Neuroscience Research Medical Group, Inc Sherman Oaks California United States 91403
12 Southern California Research LLC Simi Valley California United States 93065
13 Yale University School Of Medicine New Haven Connecticut United States 06519
14 Research Center for Clinical Studies, Inc. Norwalk Connecticut United States 06851
15 Georgetown University Medical Center Washington District of Columbia United States 20007
16 JEM Research LLC Atlantis Florida United States 33462
17 Accel Research Sites - CRU Tampa Bradenton Florida United States 34201
18 Bradenton Research Center Bradenton Florida United States 34205
19 Brain Matters Research, Inc. Delray Beach Florida United States 33445
20 ClinCloud, LLC Maitland Florida United States 32751
21 Optimus U Corp Miami Florida United States 33125
22 Allied Biomedical Research Institute, Inc Miami Florida United States 33155
23 Renstar Medical Research Ocala Florida United States 34470
24 Progressive Medical Research Port Orange Florida United States 32127
25 Intercoastal Medical Group Sarasota Florida United States 34239
26 Infinity Clinical Research, LLC Sunrise Florida United States 33351
27 Axiom Clinical Research of Florida Tampa Florida United States 33609
28 Alzheimer's Research and Treatment Center Wellington Florida United States 33414
29 Emory University Atlanta Georgia United States 30329
30 Center for Advanced Research & Education Gainesville Georgia United States 30501
31 Southern Illinois University, School of Medicine Springfield Illinois United States 62702
32 American Health Network Institute, LLC Avon Indiana United States 46123
33 Fort Wayne Neurological Center Fort Wayne Indiana United States 46805
34 Via Christi Research Wichita Kansas United States 67214
35 Brigham and Womens Hospital; Center for Alzheimer Research & Treatment Boston Massachusetts United States 02115
36 Boston Center for Memory Newton Massachusetts United States 02459
37 Precise Research Centers Flowood Mississippi United States 39232
38 University of Mississippi Medical Center Jackson Mississippi United States 39216
39 Missouri Memory Center Bolivar Missouri United States 65613
40 Washington University School of Medicine Saint Louis Missouri United States 63110
41 University of Nebraska Medical Center; Dept of Neurological Sciences Omaha Nebraska United States 68198-8440
42 Cleveland Clinic Lou Ruvo; Center for Brain Research Las Vegas Nevada United States 89106
43 The Cognitive and Research Center of New Jersey Springfield New Jersey United States 07081
44 Advanced Memory Research Institute of NJ Toms River New Jersey United States 08755
45 Neurological Associates of Long Island, PC Lake Success New York United States 11042
46 Columbia University Medical Center New York New York United States 10032
47 AD-CARE, University of Rochester Medical Center Rochester New York United States 14620
48 Richmond Behavioral Associates Staten Island New York United States 10314
49 SUNY Upstate Medical University Syracuse New York United States 13210
50 Behavioral Health Research Charlotte North Carolina United States 28211
51 Alzheimer's Memory Center Matthews North Carolina United States 28105
52 Raleigh Neurology Associates Raleigh North Carolina United States 27607-6520
53 Wake Forest University Winston-Salem North Carolina United States 27157
54 Cleveland Clinic; Cleveland Lou Ruvo Center for Brain Health - Neurological Institute Cleveland Ohio United States 44195
55 Ohio State University; College of Medicine Columbus Ohio United States 43210
56 Summit Research Network Inc. Portland Oregon United States 97210
57 Abington Neurological Associates Abington Pennsylvania United States 19001
58 The Clinical Trial Center, LLC Jenkintown Pennsylvania United States 19046
59 Senior Adults Specialty Research Austin Texas United States 78757
60 Kerwin Medical Center Dallas Texas United States 75231
61 Neurology Consultants of Dallas; Research Department Dallas Texas United States 75243
62 Alzheimers Disease & Memory Disorders Center; Department of Neurology Baylor College of Medicine Houston Texas United States 77030
63 The University of Texas Health Science Center at Houston Houston Texas United States 77054
64 Wasatch Clinical Research, LLC Salt Lake City Utah United States 84107
65 University of Virginia Charlottesville Virginia United States 22906
66 Sentara Neurology Specialists Norfolk Virginia United States 23507
67 National Clinical Research Inc.-Richmond Richmond Virginia United States 23294
68 UW Wisconsin-Madison Madison Wisconsin United States 53705
69 Hospital Italiano Caba Argentina C1199ABB
70 Universidad Maimonides Caba Argentina C1405BCK
71 Instituto Geriatrico Nuestra Señora de las Nieves Capital Federal Argentina C1427CCP
72 CEN Centro Especializado en Neurociencias Cordoba Argentina X5004FJF
73 Instituto Kremer Córdoba Argentina X5004AOA
74 Instituto de Neurociencias San Agustín S.A. La Plata Argentina B1902AVF
75 Fundación Scherbovsky; General Department Mendoza Argentina M5500AYB
76 St Vincent's Hospital Sydney; Neurology Darlinghurst New South Wales Australia 2010
77 Central Coast Neurosciences Research Erina New South Wales Australia 2250
78 Southern Neurology Kogarah New South Wales Australia 2217
79 The Queen Elizabeth Hospital; Neurology Woodville South Australia Australia 5011
80 Heidelberg Repatriation Hospital; Medical and Cognitive Research Centre Heidelberg West Victoria Australia 3081
81 Australian Alzheimer's Research Foundation Nedlands Western Australia Australia 6009
82 AZ Sint Blasius (Dendermonde) Dendermonde Belgium 9200
83 UZ Gent Gent Belgium 9000
84 Jessa Zkh (Campus Virga Jesse) Hasselt Belgium 3500
85 Hospital Nossa Senhora das Graças; Setor de Pesquisa em Neurologia Curitiba PR Brazil 80810-040
86 Instituto de Neurologia de Curitiba Curitiba PR Brazil 81210-310
87 Clinica Clinilive ltda Maringa PR Brazil 87013-250
88 Hospital das Clinicas - UFRGS Porto Alegre RS Brazil 90035-903
89 Hospital das Clinicas - FMUSP_X; Neurologia Sao Paulo SP Brazil 05403-000
90 The Medical Arts Health Research Group - West Vancouver Vancouver British Columbia Canada V7T 2Z3
91 Parkwood Hospital; Geriatric Medicine London Ontario Canada N6C 5J1
92 Sunnybrook Health Sciences Centre Toronto Ontario Canada M4N 3M5
93 Baycrest Health Sciences Toronto Ontario Canada M6A 2E1
94 Devonshire Clinical Research Woodstock Ontario Canada N4S 5P5
95 Center for Diagnosis and Research on Alzheimer's disease Greenfield Park Quebec Canada J4V 2J2
96 Alpha Recherche Clinique Quebec Canada G3K 2P8
97 Psicomed Estudios Médicos Antofagasta Chile 1270244
98 Biomedica Research Group Santiago Chile 7500710
99 Especialidades Medicas LYS Santiago Chile 7560356
100 Beijing Tian Tan Hospital,Capital Medical University Beijing China
101 Clinical Hospital Centre Zagreb;Clinic for Neurology Zagreb Croatia 10000
102 Aarhus Universitetshospital, Neurologisk Afdeling F, Demensklinikken Aarhus N Denmark 8200
103 Rigshospitalet, Hukommelsesklinikken Koebenhavn Oe Denmark 2100
104 Svendborg Sygehus; Neurologisk afdeling N, Demensklinik Fyn Svendborg Denmark 5700
105 Terveystalo Ruoholahti Helsinki Finland 00180
106 Itä-Suomen yliopisto, Kuopion kampus Kuopio Finland 70210
107 CHU Amiens Hopital Sud; Neurologie Amiens Cedex1 France 80054
108 Hôpital Avicenne; Centre de Recherche Clinique Bobigny Cedex France 93009
109 Groupement Hospitalier Est - Hôpital Neurologique; Neurologie A (U502) Bron cedex France 69677
110 CHU de la Timone - Hopital d Adultes; Service de Neurologie Marseille France 13005
111 Hôpital Lariboisière Paris France 75010
112 CHU Poitiers - Hopital La Miletrie Poitiers France 86000
113 CHU Strasbourg - Hôpital Hautepierre Strasbourg France 67098
114 Gerontopole; Centre de Recherche clinique Toulouse France 31059
115 Hopital des Charpennes Villeurbanne France 69100
116 Ambulates Gesundheitszentrum der Charité GmbH; MVZ Neurologie Campus Benjamin Franklin Berlin Germany 12200
117 ECRC Experimental and Clinical Research Center, Charité Campus Berlin Buch, Memory Clinic Berlin Germany 13125
118 Universitätsklinikum Köln; Klinik und Poliklinik für Psychiatrie und Psychotherapie Köln Germany 50937
119 PANAKEIA - Arzneimittelforschung Leipzig GmbH Leipzig Germany 04275
120 Universitätsmedizin derJohannes Gutenberg-Universität Mainz;Klinik für Psychiatrie und Psychotherapi Mainz Germany 55131
121 Klinikum rechts der Isar der TU München; Klinik für Psychiatrie und Psychotherapie München Germany 81675
122 Universitätsklinikum Münster; Klinik und Poliklinik für Neurologie Münster Germany 48149
123 Universitätsklinikum Rostock Zentrum für Nervenheilkunde Rostock Germany 18147
124 Universitätsklinikum Ulm; Klinik für Neurologie Ulm Germany 89081
125 Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz Westerstede Germany 26655
126 Forschungszentrum Ruhr Witten Germany 58455
127 Semmelweis University; Department of Neurology Budapest Hungary 1083
128 Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze Modena Emilia-Romagna Italy 41126
129 Fondazione Santa Lucia IRCCS; Neurologia e Riabilitazione Neurologica Roma Lazio Italy 00179
130 Umberto I Policlinico di Roma-Università di Roma La Sapienza Roma Lazio Italy 00185
131 Ospedale San Giovanni Calibita Fatebenefratell;Neurologia Roma Lazio Italy 00186
132 IRCCS "Centro S. Giovanni di Dio" Fatebenefratelli -UO Alzheimer Brescia Lombardia Italy 25125
133 IRCCS Ospedale San Raffaele; Centro Disturbi della Memoria Milano Lombardia Italy 20132
134 ASST DI MONZA; Neurologia Monza Lombardia Italy 20900
135 IRCCS Neuromed; Neurologia I-Centro studio e cura delle demenze e UVA Pozzilli Molise Italy 86077
136 AO Città della Salute e della Scienza Osp.S.Giov.Battista Molinette; SC Geriatria Torino Piemonte Italy 10126
137 Dipartimento delle Patologie Emergenti; Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo Sicilia Italy 90127
138 Yachiyo Hospital Aichi Japan 446-8510
139 Nagoya Ekisaikai Hospital Aichi Japan 454-8502
140 National Center for Geriatrics and Gerontology Aichi Japan 474-8511
141 Medical Corporation Hakuyokai Kashiwado Hospital Chiba Japan 260-8656
142 Tokyo Bay Advanced Medical and Makuhari Clinic Chiba Japan 261-0024
143 Inage Neurology and Memory Clinic Chiba Japan 263-0043
144 Juntendo University Urayasu Hospital Chiba Japan 279-0021
145 Fukuoka University Hospital Fukuoka Japan 814-0180
146 Southern Tohoku Medical Clinic Fukushima Japan 963-8052
147 National Hospital Organization Hiroshima-Nishi Medical Center Hiroshima Japan 739-0696
148 Kobe University Hospital Hyogo Japan 650-0017
149 Hyogo Prefectural HarimaHimeji General Medical Center Hyogo Japan 670-8560
150 Tsukazaki Hospital Hyogo Japan 671-1227
151 Matsui Dietary and Dementia Clinic Hyogo Japan 673-0891
152 Kagawa Prefectural Central Hospital Kagawa Japan 760-8557
153 Yuai Clinic Kanagawa Japan 223-0059
154 Shonan Kamakura General Hospital Kanagawa Japan 247-8533
155 Rakuwakai Otowa Hospital Kyoto Japan 607-8062
156 Uji Takeda Hospital Kyoto Japan 611-0021
157 Mishima Hospital Niigata Japan 940-2302
158 Okayama Kyokuto Hospital Okayama Japan 703-8265
159 Rijikai Medical Corporation Katayama Medical Clinic Okayama Japan 710-0813
160 MI Clinic Osaka Japan 560-0004
161 Kishiwada Tokushukai Hospital Osaka Japan 596-0042
162 National Hospital Organization Hizen Psychiatric Medical Center Saga Japan 842-0192
163 NHO Shizuoka Institute of Epilepsy and Neurological Disorders Shizuoka Japan 420-8688
164 Shizuoka City Shimizu Hospital Shizuoka Japan 424-0911
165 Jichiidai Station Brain Clinic Tochigi Japan 329-0403
166 Medical corporation Ichiekai Itsuki Hospital Tokushima Japan 770-0852
167 Tokushima Hospital Tokushima Japan 776-8585
168 Yotsuya Medical Cube Tokyo Japan 102-0084
169 Tokyo Medical and Dental University Hospital Tokyo Japan 113-8519
170 Tokyo Medical University Hospital Tokyo Japan 160-0023
171 Nozomi Memory Clinic Tokyo Japan 181-0013
172 National Center of Neurology and Psychiatry Tokyo Japan 187-8551
173 P-One Clinic Tokyo Japan 192-0071
174 Yamagata Tokusyukai Hospital Yamagata Japan 990-0834
175 Dong-A University Hospital Busan Korea, Republic of 49201
176 Myongji Hospital Gyeonggi-do Korea, Republic of 10475
177 Gachon University Gil Medical Center Incheon Korea, Republic of 21565
178 Inha University Hospital Incheon Korea, Republic of 22332
179 Seoul National University Bundang Hospital Seongnam-si Korea, Republic of 13605
180 Hanyang University Seoul Hospital Seoul Korea, Republic of 04763
181 Konkuk University Medical Center Seoul Korea, Republic of 05030
182 Asan Medical Center Seoul Korea, Republic of 05505
183 Samsung Medical Center Seoul Korea, Republic of 06351
184 Seoul St Mary's Hospital Seoul Korea, Republic of 06591
185 Ewha Womans University Hospital (Seoul) Seoul Korea, Republic of 07804
186 Vilnius University Hospital Santariskiu Clinics; Neurology Vilnius Lithuania 08661
187 Mexico Centre for Clinical Research Ciudad de México Mexico CITY (federal District) Mexico 03100
188 Hospital Angeles de Culiacán, Neurociencias Estudios Clínicos SC Culiacan Mexico 80020
189 Hospital Universitario Dr Jose Eleuterio Gonzalez UANL; Depto.de NeurologíaPta.BajaConsulta Monterrey Mexico 64460
190 AVIX Investigación Clínica S.C Monterrey Mexico 64710
191 Brain Research Center B.V Amsterdam Netherlands 1081 GN
192 Hospital IV Alberto Sabogal Sologuren; Unidad de Investigacion Bellavista Peru Callao 2
193 Clinica Internacional; Unidad De Investigacion Lima Peru 15001
194 Hospital Nacional Dos de Mayo; Unidad de Investigacion de Neurologia Lima Peru 15003
195 Podlaskie Centrum Psychogeriatrii Białystok Poland 15-756
196 NZOZ Vitamed Bydgoszcz Poland 85-079
197 KO-MED Centra Kliniczne Lublin II Lublin Poland 20-362
198 Neurologiczny NZOZ Centrum Leczenia SM; Osrodek Badan Klinicznych Plewiska Poland 62-064
199 NEURO-CARE Sp. z o.o. Sp. Komandytowa Siemianowice Śląskie Poland 41-100
200 Senior Sp. Z O.O. Poradnia Psychogeriatryczna Sopot Poland 81-855
201 mMED Maciej Czarnecki Warszawa Poland 01-684
202 Pratia S.A. Warszawa Poland 01-868
203 NZOZ WCA Wrocław Poland 53-659
204 Ośrodek Badawczo-Naukowo-Dydaktyczny Chorób Otępiennych w Ścinawie Ścinawa Poland 59-330
205 Hospital de Braga; Servico de Neurologia Braga Portugal 4710-243
206 HUC; Servico de Neurologia Coimbra Portugal 3000-075
207 Hospital da Senhora da Oliveira-Guimarães; Serviço de Neurologia Guimarães Portugal
208 Hospital Geral de Santo Antonio; Servico de Neurologia Porto Portugal 4099-001
209 Santa Cruz Behavioral PSC Bayamon Puerto Rico 00961
210 University of Puerto Rico - Medical Science Campus; Internal Medicine San Juan Puerto Rico 00936
211 FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency Krasnoyarsk Krasnojarsk Russian Federation 660037
212 University сlinic of headaches Moscow Moskovskaja Oblast Russian Federation 121467
213 City Polyclinic No. 2 of the Department of Healthcare of the City of Moscow Moskva Moskovskaja Oblast Russian Federation 117556
214 FSBMEI HPE "Military Medical Academy n.a. S.M. Kirov" of the MoD of the RF Sankt-peterburg Sankt Petersburg Russian Federation 194044
215 State Autonomous Healthcare Institution "Republican Clinical Neurological Center Kazan Russian Federation 420021
216 State autonomous institution of healthcare Inter-regional clinical and diagnostic center Kazan Russian Federation 420101
217 City Clin Hosp n.a. S.P.Botkin Moscow Russian Federation 125101
218 MHI City Clinical Hospital #2 named after V.I. Razumovsky; Psychiatric Sartatov Russian Federation 410028
219 Nebbiolo Center for Clinical Trials Tomsk Russian Federation 634009
220 National University Hospital (NUH); Neuroscience Singapore Singapore 117549
221 National Neuroscience Institute; Neurology Singapore Singapore 308433
222 Hospital General Universitario de Elche; Servicio de Neurología Elche Alicante Spain 03203
223 Hospital Universitari de Bellvitge; Servicio de Neurologia L'Hospitalet de Llobregat Barcelona Spain 08907
224 Hospital General De Catalunya; Servicio de Neurologia Sant Cugat del Valles Barcelona Spain 8195
225 Hospital Mutua De Terrasa; Servicio de Neurologia Terrassa Barcelona Spain 08222
226 Hospital Virgen del Puerto. Servicio de Neurología Plasencia Caceres Spain 10600
227 Hospital Universitario Marques de Valdecilla; Servicio de Neurología SANtander Cantabria Spain 39011
228 Policlínica Guipuzcoa; Servicio de Neurología Donostia-san Sebastian Guipuzcoa Spain 20014
229 Hospital San Pedro; Servicio de Neurología Logroño LA Rioja Spain 26006
230 Hospital Universitario de Santa Maria; Servicio de Neurología Lleida Lerida Spain 25198
231 HM Universitario Puerta del Sur CINAC (C.Integ.Neuroc);; Servicio de Psiquiatría Móstoles Madrid Spain 28938
232 Hospital Quiron de Madrid; Servicio de Neurologia Pozuelo de Alarcon Madrid Spain 28223
233 Clinica Universitaria de Navarra; Servicio de Neurología Pamplona Navarra Spain 31008
234 Clinica Universitaria de Navarra Pamplona Navarra Spain 31008
235 Complejo Asistencial Universitario de Salamanca; Servicio de Psiquiatría Salamaca Salamanca Spain 37007
236 CAE OROITU; Servicio de Neurología Getxo Vizcaya Spain 48993
237 Hospital General Universitario de Albacete; Servicio de Neurología Albacete Spain
238 Hospital del Mar; Servicio de Neurologia Barcelona Spain 08003
239 Fundación ACE; Servicio de Neurología Barcelona Spain 08028
240 Hospital Vall d'Hebron; Servicio de Neurología Barcelona Spain 08035
241 Hospital Clinic i Provincial; Servicio de Neurologia Barcelona Spain 08036
242 Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia Barcelona Spain 08041
243 Hospital Universitario Reina Sofia; Servicio de Neurologia Cordoba Spain 14011
244 Universitario de La Princesa; Servicio de Neurología Madrid Spain 28006
245 Hospital Ramon y Cajal; Servicio de Neurologia Madrid Spain 28034
246 Hospital Ruber Internacional; Servicio de Neurología Madrid Spain 28034
247 Hospital Universitario 12 de Octubre; Servicio de Neurologia Madrid Spain 28041
248 Hospital Virgen del Rocío; Servicio de Neurología Sevilla Spain 41013
249 Hospital Victoria Eugenia; Servico Neurología Sevilla Spain
250 Hospital Universitario Dr. Peset; Servicio de Neurologia Valencia Spain 46017
251 Hospital Universitario la Fe; Servicio de Neurologia Valencia Spain 46026
252 Complejo Asistencial de Zamora; Servicio Psiquiatria Zamora Spain 49021
253 Servicio de Neurología Hospital Viamed Montecanal. Zaragoza Spain 50012
254 Skånes Universitetssjukhus Malmö, Minneskliniken Malmö Sweden 211 46
255 Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry Mölndal Sweden 431 41
256 KAROLINSKA UNI HOSPITAL, HUDDINGE; Mottagning Kognitiv Forskning, M54 Stockholm Sweden 141 86
257 Changhua Christian Hospital; Neurology Changhua County Taiwan 500
258 Kaohsiung Medical University Hospital; Neurology Kaohsiung Taiwan 807
259 Chang Gung Memorial Foundation - Kaohsiung - Neurology Niaosong Dist. Taiwan 83301
260 China Medical University Hospital; Neurology North Dist. Taiwan 40447
261 National Taiwan University Hospital; Neurology Taipei Taiwan 100
262 Chang Gung Memorial Foundation - Linkou - Neurology Taoyuan Taiwan 333
263 Istanbul University Istanbul School of Medicine; Neurology Istanbul Turkey 34093
264 Ondokuz Mayis Univ. Med. Fac.; Neurology Samsun Turkey 55139
265 The Rice Centre; Royal United Hospital Bath United Kingdom BA1 3NG
266 Re:Cognition Health Birmingham Birmingham United Kingdom B16 8LT
267 The Fritchie Centre, Charlton Lane Centre, Charlon Lane, Leckhampton; The Fritchie Centre Cheltenham United Kingdom GL53 9DZ
268 Surrey and Borders NHS Foundation Trust; Research and Development Departmant; Abraham Cowley Unit Chertsey United Kingdom KT16 9AU
269 Sussex Partnership NHS Foundation Trust; Cognitive Treatment and Research unit Crowborough United Kingdom TN6 1HB
270 Ninewells Hospital Dundee United Kingdom DD12 9SY
271 Queen Elizabeth University Hospital - PPDS Glasgow United Kingdom G51 4TF
272 St George's Hospital London United Kingdom SW17 ORE
273 Re:Cognition Health London London United Kingdom W1G 9RU
274 Charing Cross Hospital London United Kingdom W6 8RF
275 Campus for Ageing and Vitality Newcastle United Kingdom NE4 5PL
276 Royal Hallamshire Hospital Sheffield Teaching Hospitals NHS Foundation Trust Sheffield United Kingdom S10 2JF
277 University Southampton NHS Foundation Trust; Wessex Neurologica Centre Southampton United Kingdom SO166YD

Sponsors and Collaborators

  • Hoffmann-La Roche

Investigators

  • Study Director: Clinical Trials, Hoffmann-La Roche

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hoffmann-La Roche
ClinicalTrials.gov Identifier:
NCT04374253
Other Study ID Numbers:
  • WN42171
  • 2020-000766-42
First Posted:
May 5, 2020
Last Update Posted:
Aug 2, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 2, 2022